These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum. Michiba K; Maeda K; Kurimori K; Enomoto T; Shimomura O; Takeuchi T; Nishiyama H; Oda T; Kusuhara H Drug Metab Dispos; 2021 Jan; 49(1):84-93. PubMed ID: 33087448 [TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin based nanosponge of norfloxacin: Intestinal permeation enhancement and improved antibacterial activity. Mendes C; Meirelles GC; Barp CG; Assreuy J; Silva MAS; Ponchel G Carbohydr Polym; 2018 Sep; 195():586-592. PubMed ID: 29805015 [TBL] [Abstract][Full Text] [Related]
4. The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison. Weinheimer M; Fricker G; Burhenne J; Mylius P; Schubert R Eur J Pharm Sci; 2017 Oct; 108():13-22. PubMed ID: 27590127 [TBL] [Abstract][Full Text] [Related]
5. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
6. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine. Dahan A; Sabit H; Amidon GL Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874 [TBL] [Abstract][Full Text] [Related]
7. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Dahan A; Amidon GL Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926 [TBL] [Abstract][Full Text] [Related]
8. Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5. Arakawa H; Shirasaka Y; Haga M; Nakanishi T; Tamai I Biopharm Drug Dispos; 2012 Sep; 33(6):332-41. PubMed ID: 22899169 [TBL] [Abstract][Full Text] [Related]
9. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2. Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576 [TBL] [Abstract][Full Text] [Related]
10. Targeting intestinal transporters for optimizing oral drug absorption. Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135 [TBL] [Abstract][Full Text] [Related]
11. The potential of immobilized artificial membrane chromatography to predict human oral absorption. Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A Eur J Pharm Sci; 2016 Jan; 81():82-93. PubMed ID: 26485055 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. Sjöberg Å; Lutz M; Tannergren C; Wingolf C; Borde A; Ungell AL Eur J Pharm Sci; 2013 Jan; 48(1-2):166-80. PubMed ID: 23103351 [TBL] [Abstract][Full Text] [Related]
13. Intestinal drug transporters: an overview. Estudante M; Morais JG; Soveral G; Benet LZ Adv Drug Deliv Rev; 2013 Oct; 65(10):1340-56. PubMed ID: 23041352 [TBL] [Abstract][Full Text] [Related]
14. The Ussing Chamber Assay to Study Drug Metabolism and Transport in the Human Intestine. Kisser B; Mangelsen E; Wingolf C; Partecke LI; Heidecke CD; Tannergren C; Oswald S; Keiser M Curr Protoc Pharmacol; 2017 Jun; 77():7.17.1-7.17.19. PubMed ID: 28640954 [TBL] [Abstract][Full Text] [Related]
15. Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model. Zheng M; Zhou H; Wan H; Chen YL; He Y J Ethnopharmacol; 2015 Apr; 164():22-9. PubMed ID: 25660335 [TBL] [Abstract][Full Text] [Related]
16. Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats. Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M J Pharm Pharmacol; 2007 Sep; 59(9):1263-70. PubMed ID: 17883898 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cytotoxicity and intestinal absorption of a self-emulsifying drug delivery system containing sodium taurocholate. Gao H; Wang M; Sun D; Sun S; Sun C; Liu J; Guan Q Eur J Pharm Sci; 2017 Aug; 106():212-219. PubMed ID: 28591563 [TBL] [Abstract][Full Text] [Related]
18. Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques. Mariappan TT; Singh S Mol Pharm; 2004; 1(5):363-7. PubMed ID: 16026006 [TBL] [Abstract][Full Text] [Related]
19. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
20. Intestinal absorption pathways of lisinopril: Mechanistic investigations. Elewa SH; Osman MA; Essa EA; Sultan AA Biopharm Drug Dispos; 2022 Dec; 43(6):233-246. PubMed ID: 36299167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]